Skip to main content
. 2022 Mar 4;37(3):390–397. doi: 10.1016/j.virs.2022.03.001

Fig. 2.

Fig. 2

HBsAg and HBeAg responses in patients who received different consolidation treatment. HBsAg, hepatitis B surface antigen; HBeAg, hepatitis B e antigen; NS, not significant.